Published in Proc Natl Acad Sci U S A on August 18, 1998
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2004) 4.00
Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J Virol (2000) 3.74
Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol (2000) 3.39
Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev (2001) 3.33
Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol (2009) 2.05
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J Virol (2002) 1.93
The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol (2000) 1.81
Emergence of fatal avian influenza in New England harbor seals. MBio (2012) 1.70
Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog (2013) 1.64
Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res (2008) 1.47
Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. J Virol (2004) 1.46
1918 Spanish influenza: the secrets remain elusive. Proc Natl Acad Sci U S A (1999) 1.42
An enzymatic virus-like particle assay for sensitive detection of virus entry. J Virol Methods (2009) 1.42
Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol (2010) 1.40
Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol (2011) 1.35
Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication. J Virol (2005) 1.31
Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter. Proc Natl Acad Sci U S A (1998) 1.28
Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. J Virol (2001) 1.28
Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication. J Virol (2009) 1.26
Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol (2006) 1.24
Subcellular localization and calcium and pH requirements for proteolytic processing of the Hendra virus fusion protein. J Virol (2004) 1.23
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol (2008) 1.23
Reverse genetics of negative-strand RNA viruses: closing the circle. Proc Natl Acad Sci U S A (1999) 1.23
An experimentally determined evolutionary model dramatically improves phylogenetic fit. Mol Biol Evol (2014) 1.19
Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J Virol (2010) 1.19
The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin. Elife (2014) 1.18
Plasmin-coated borrelia Burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix. Infect Immun (1999) 1.16
Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol (2002) 1.14
Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses (2012) 1.07
Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. J Virol (2012) 1.03
Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun (2009) 1.01
From touchdown to transcription: the reovirus cell entry pathway. Curr Top Microbiol Immunol (2010) 1.01
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog (2013) 1.00
PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest (2012) 1.00
Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J Virol (2002) 0.99
TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice. J Virol (2014) 0.99
In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans. PLoS One (2010) 0.98
Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection. Virol J (2011) 0.93
The low-pH stability discovered in neuraminidase of 1918 pandemic influenza A virus enhances virus replication. PLoS One (2010) 0.91
The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. Med Microbiol Immunol (2007) 0.91
Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin. Viruses (2016) 0.89
Determinants of virulence of influenza A virus. Eur J Clin Microbiol Infect Dis (2013) 0.89
H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A (2015) 0.89
Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function. J Virol (2004) 0.89
Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses. J Virol (1999) 0.88
Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity. PLoS One (2011) 0.88
Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells. PLoS One (2012) 0.88
TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol (2013) 0.86
Permissive and restricted virus infection of murine embryonic stem cells. J Gen Virol (2012) 0.86
Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase. J Virol (2013) 0.86
Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase. BMC Struct Biol (2010) 0.85
High permissivity of human HepG2 hepatoma cells for influenza viruses. J Clin Microbiol (2004) 0.84
Identification of critical residues of influenza neuraminidase in viral particle release. Virol J (2011) 0.83
Modulation of an ectodomain motif in the influenza A virus neuraminidase alters tetherin sensitivity and results in virus attenuation in vivo. J Mol Biol (2013) 0.82
Leptospira interrogans enolase is secreted extracellularly and interacts with plasminogen. PLoS One (2013) 0.81
H4N8 subtype avian influenza virus isolated from shorebirds contains a unique PB1 gene and causes severe respiratory disease in mice. Virology (2011) 0.81
The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells. PLoS One (2016) 0.80
Genetic changes that accompanied shifts of low pathogenic avian influenza viruses toward higher pathogenicity in poultry. Virulence (2013) 0.79
Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol (2016) 0.78
Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge. J Virol (2014) 0.78
Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients. Int J Chron Obstruct Pulmon Dis (2007) 0.77
Gangliosides are not essential for influenza virus infection. Glycoconj J (2006) 0.77
Features of two new proteins with OmpA-like domains identified in the genome sequences of Leptospira interrogans. PLoS One (2015) 0.76
Modification of the hemagglutinin cleavage site allows indirect activation of avian influenza virus H9N2 by bacterial staphylokinase. Virology (2015) 0.76
Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference. J Virol (2016) 0.76
Deep mutational scanning identifies sites in influenza nucleoprotein that affect viral inhibition by MxA. PLoS Pathog (2017) 0.75
Molecular determinants of influenza virus pathogenesis in mice. Curr Top Microbiol Immunol (2014) 0.75
Involvement of non-structural proteins (NS) in influenza A infection and viral tropism. Biochem Biophys Res Commun (2012) 0.75
Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response. PLoS One (2015) 0.75
Influenza A Virus Hemagglutinin is Required for the Assembly of Viral Components Including Bundled vRNPs at the Lipid Raft. Viruses (2016) 0.75
Characterization of Variations in PB2, NS1, M, Neuraminidase and Hemagglutinin of Influenza A (H3N2) Viruses in Iran. Jundishapur J Microbiol (2014) 0.75
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Initial genetic characterization of the 1918 "Spanish" influenza virus. Science (1997) 10.17
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology (1975) 6.90
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature (1983) 5.56
Host cell proteases controlling virus pathogenicity. Trends Microbiol (1994) 4.71
Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells. J Virol (1977) 4.52
Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity. Virology (1969) 4.45
The sequence of the nucleoprotein gene of human influenza A virus, strain A/NT/60/68. Nucleic Acids Res (1982) 3.99
The neuraminidase of influenza virus. Proteins (1989) 3.54
Biologic importance of neuraminidase stalk length in influenza A virus. J Virol (1993) 3.51
The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J (1992) 3.21
Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry (1991) 2.66
Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol (1993) 2.40
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology (1973) 2.01
The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor. Proc Natl Acad Sci U S A (1994) 1.76
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol (1994) 1.76
Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology (1994) 1.44
The kidney is a major site of alpha(2)-antiplasmin production. J Clin Invest (1996) 1.06
Cellular receptors in the regulation of plasmin generation. Thromb Haemost (1995) 1.06
Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science (2001) 18.43
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 8.44
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol (2000) 8.28
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99
The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol (1999) 7.89
A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 4.44
Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology (1993) 4.40
Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24
Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology (1984) 4.15
Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis (1996) 4.04
Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol (1991) 4.01
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology (1993) 3.54
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54
Biologic importance of neuraminidase stalk length in influenza A virus. J Virol (1993) 3.51
Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol (2001) 3.41
Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol (1990) 3.40
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol (1992) 3.37
Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev (2001) 3.33
Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol (1994) 3.31
Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol (1991) 3.29
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology (1997) 3.10
Sialic acid species as a determinant of the host range of influenza A viruses. J Virol (2000) 3.10
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol (1998) 3.07
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol (1997) 3.00
Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology (1995) 2.99
Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75
Nuclear import and export of influenza virus nucleoprotein. J Virol (1997) 2.69
Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J (2000) 2.54
Emergence of avian H1N1 influenza viruses in pigs in China. J Virol (1996) 2.44
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
Evolution of the nucleoprotein gene of influenza A virus. J Virol (1990) 2.40
Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs. Arch Virol (1995) 2.38
Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol (1997) 2.38
Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J Virol (1992) 2.37
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. Virology (1987) 2.30
"Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology (2000) 2.22
Infection of children with avian-human reassortant influenza virus from pigs in Europe. Virology (1994) 2.21
Wild ducks are the reservoir for only a limited number of influenza A subtypes. Epidemiol Infect (1993) 2.21
Plasmid-driven formation of influenza virus-like particles. J Virol (2000) 2.18
Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation. J Virol (1993) 2.15
Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol (2001) 2.13
Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J Clin Microbiol (1989) 2.09
Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol (2004) 2.04
Influenza viral infection of swine in the United States 1988-1989. Arch Virol (1991) 2.02
Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy. Virology (1997) 1.98
Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J Virol (1994) 1.93
Characterization of a new avian-like influenza A virus from horses in China. Virology (1992) 1.90
Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. Vet Microbiol (2000) 1.86
Evolution of the hemagglutinin of equine H3 influenza viruses. Virology (1989) 1.83
Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J Virol (1999) 1.78
Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J Virol (2001) 1.77
Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology (1995) 1.75
Evolutionary pathways of the PA genes of influenza A viruses. Virology (1989) 1.70
Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein. J Virol (1995) 1.68
Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol (2001) 1.67
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine (1991) 1.66
Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol (2000) 1.63
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
Coinfection of wild ducks by influenza A viruses: distribution patterns and biological significance. J Virol (1997) 1.60
Functional importance of the coiled-coil of the Ebola virus glycoprotein. J Virol (2000) 1.59
Antigenic and molecular characterization of subtype H13 hemagglutinin of influenza virus. Virology (1989) 1.59
DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol (1999) 1.57
Application of Directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens. J Clin Microbiol (1992) 1.54
Host-range barrier of influenza A viruses. Vet Microbiol (2000) 1.54
Infectivity-enhancing antibodies to Ebola virus glycoprotein. J Virol (2001) 1.52
Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus. J Virol (1994) 1.52
Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions. J Virol (1993) 1.51
Distinct lineages of influenza virus H4 hemagglutinin genes in different regions of the world. Virology (1989) 1.51
Nucleotide sequence of the avian influenza A/Mallard/NY/6750/78 virus polymerase genes. Virus Res (1989) 1.49
The pathogenesis of Ebola hemorrhagic fever. Trends Microbiol (2001) 1.49
Antigenic and genetic conservation of H3 influenza virus in wild ducks. Virology (1987) 1.47
Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host. J Virol (1998) 1.47
Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium. FEBS Lett (1997) 1.46
Influenza: interspecies transmission and emergence of new pandemics. FEMS Immunol Med Microbiol (1997) 1.46
Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes. Adv Virus Res (1999) 1.46
Location and character of the cellular enzyme that cleaves the hemagglutinin of a virulent avian influenza virus. Virology (1992) 1.38
Molecular analysis of the hemagglutinin genes of Australian H7N7 influenza viruses: role of passerine birds in maintenance or transmission? Virology (1987) 1.38
Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Virology (1997) 1.37
Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine (1988) 1.35
Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice. J Virol (2000) 1.34
Distinct glycoprotein inhibitors of influenza A virus in different animal sera. J Virol (1991) 1.33
Molecular changes in A/Chicken/Pennsylvania/83 (H5N2) influenza virus associated with acquisition of virulence. Virology (1986) 1.33
Pathological studies of chickens experimentally infected with two highly pathogenic avian influenza viruses. Avian Pathol (1996) 1.32
Influenza--a model of an emerging virus disease. Intervirology (1993) 1.31
Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. Curr Top Microbiol Immunol (2004) 1.28
Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. J Virol (2001) 1.28
Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine. J Virol (2001) 1.27
Prospective systematic study of Yersinia spp. in dogs. J Clin Microbiol (1984) 1.26
Continued circulation of reassortant H1N2 influenza viruses in pigs in Japan. Arch Virol (1998) 1.25